GGrantIndex
← Leaderboards

Alfred K. Cheung

University Of Utah

$14,284,841
Attributed
$17,190,070
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY200625
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$17,190,070 · 8

By mechanism

R01$12,366,773 · 3
U01$3,813,148 · 3
TL1$664,393 · 1
T32$345,756 · 1

Most similar at University Of Utah

Same institution · by research overlap

Others in their field

Top investigators on “Hemodialysis

Research focus

HemodialysisKidney DiseasesClinical ResearchUtahDesignFutureAncillary StudyChronicAnimalsCohort StudiesNational Institute Of Diabetes And Digestive And Kidney DiseasesMediatingBloodBlood VesselsClinical TrialsDialysis ProcedureVenousBiologicalFailure (Biologic Function)MonitorGenerationsFollow-UpChronic Kidney FailureClinical Care

Grant awards (35)

Mountain States Advancement in Research, Supportive Networking and Career Development (ASCEND)$664,393
TL1 · FY2025 · DK
Oral Sodium Bicarbonate to Slow Chronic Kidney Disease Progression$2,000
U01 · FY2018 · DK · contact PI
Oral Sodium Bicarbonate to Slow Chronic Kidney Disease Progression$291,888
U01 · FY2017 · DK · contact PI
Pathophysiological role of prorenin in CKD$280,870
R01 · FY2017 · DK · contact PI
Oral Sodium Bicarbonate to Slow Chronic Kidney Disease Progression$287,816
U01 · FY2016 · DK · contact PI
Pathophysiological role of prorenin in CKD$279,238
R01 · FY2016 · DK · contact PI
Pathophysiological role of prorenin in CKD$379,277
R01 · FY2015 · DK · contact PI
Oral Sodium Bicarbonate to Slow Chronic Kidney Disease Progression$292,231
U01 · FY2015 · DK · contact PI
Hemodynamics and Vascular Wall Biology Determine Arteriovenous Fistula Maturation$638,855
R01 · FY2014 · DK · contact PI
Pathophysiological role of prorenin in CKD$392,631
R01 · FY2014 · DK · contact PI
Oral Sodium Bicarbonate to Slow Chronic Kidney Disease Progression$293,124
U01 · FY2014 · DK · contact PI
Hemodynamics and Vascular Wall Biology Determine Arteriovenous Fistula Maturation$618,559
R01 · FY2013 · DK · contact PI
Pathophysiological role of prorenin in CKD$433,610
R01 · FY2013 · DK · contact PI
Oral Sodium Bicarbonate to Slow Chronic Kidney Disease Progression$305,673
U01 · FY2013 · DK · contact PI
Hemodynamics and Vascular Wall Biology Determine Arteriovenous Fistula Maturation$609,900
R01 · FY2012 · DK · contact PI
Maturation of Hemodialysis Arteriovenous Fistulas$160,482
U01 · FY2012 · DK · contact PI
Hemodynamics and Vascular Wall Biology Determine Arteriovenous Fistula Maturation$721,587
R01 · FY2011 · DK · contact PI
Maturation of Hemodialysis Arteriovenous Fistulas$333,814
U01 · FY2011 · DK · contact PI
Training Program in Nephrology Research$129,289
T32 · FY2011 · DK · contact PI
Prevention of Hemodialysis Vascular Access Stenosis$1,114,245
R01 · FY2010 · HL · contact PI
Maturation of Hemodialysis Arteriovenous Fistulas$323,463
U01 · FY2010 · DK · contact PI
Training Program in Nephrology Research$100,047
T32 · FY2010 · DK · contact PI
Prevention of Hemodialysis Vascular Access Stenosis$1,103,993
R01 · FY2009 · HL · contact PI
Maturation of Hemodialysis Arteriovenous Fistulas$339,630
U01 · FY2009 · DK · contact PI
Maturation of Hemodialysis Arteriovenous Fistulas$320,483
U01 · FY2009 · DK · contact PI
Training Program in Nephrology Research$116,420
T32 · FY2009 · DK · contact PI
Prevention of Hemodialysis Vascular Access Stenosis$1,050,526
R01 · FY2008 · HL · contact PI
Maturation of Hemodialysis Arteriovenous Fistulas$324,836
U01 · FY2008 · DK · contact PI
Prevention of Hemodialysis Vascular Access Stenosis$1,045,217
R01 · FY2007 · HL · contact PI
Prevention of Hemodialysis Vascular Access Stenosis$1,048,737
R01 · FY2006 · HL · contact PI
PREVENTION OF HEMODIALYSIS VASCULAR ACCESS STENOSIS$887,386
R01 · FY2004 · HL
PREVENTION OF HEMODIALYSIS VASCULAR ACCESS STENOSIS$867,224
R01 · FY2003 · HL
PREVENTION OF HEMODIALYSIS VASCULAR ACCESS STENOSIS$894,918
R01 · FY2002 · HL
CLINICAL OUTCOME OF HEMODIALYSIS IN UTAH$292,251
U01 · FY2001 · DK
CLINICAL OUTCOME OF HEMODIALYSIS IN UTAH$245,457
U01 · FY2000 · DK